As the year comes to an end, it is time to reflect and summarize our progress. We are now concluding year three of our four-year strategic period. Are we moving in the right direction to ensure that Flemingsberg becomes the obvious choice for establishments in southern Stockholm, offering a world-class innovation environment?
Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.
As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.
BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.
We share our insights from two intensive days in Luleå focused on green industrial transformation, the significance and growth potential of the gaming industry, and how to build relationship-driven communities. We return to Flemingsberg with a continued strong belief in the immense potential of collaboration and cooperation.
Every two years, Karolinska Institutet and Karolinska University Hospital jointly organize the Collaboration in Science conference. This event serves as a meeting place designed to strengthen and promote translational research collaborations between basic and clinical research. It also functions as a platform for those seeking a deeper insight into their colleagues' ongoing projects or exploring the services offered by core facilities.
The music world can be a challenging place, both for organizers trying to reach their audience and for music lovers searching for events that suit their taste. Sally Sow, the winner of the Flemingsberg Science Award IDEA 2024, has developed Turn Up, a platform that simplifies organizing, discovering, and participating in local music events. With a focus on inclusion and accessibility, she aims to create a music scene where everyone feels welcome.
Today the Flemingsberg Science Foundation announces that Miltenyi Biotec Nordics has become a Trusted Partner, entering into a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.
Södertörn University is looking for an Innovation Advisor to develop its innovation support and lead Innovation Station – the university's very own hub for collaboration, idea development, and coworking
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.